|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -99.80% |
| 01-26 | Mali takes 51% stake in China-backed local explosives venture | RE |
| 25-02-05 | Allied Corp. Announces Resignation of Calum Hughes as Chief Executive Officer | CI |
| Market Cap | 1.3M 1.12M 1.03M 971K 1.82M 123M 1.84M 12.22M 4.76M 60.36M 4.89M 4.79M 209M | P/E Ratio 2023 |
-2.13x | P/E Ratio 2024 | -2.52x |
|---|---|---|---|---|---|
| Enterprise Value | 7.55M 6.51M 5.99M 5.63M 10.56M 714M 10.68M 70.81M 27.59M 350M 28.34M 27.74M 1.21B | EV / Sales 2023 |
394,366,816x | EV / Sales 2024 | 171,944,593x |
| Free-Float |
52.84% | Yield 2023 * |
-
| Yield 2024 | - |
| Current year | 0 | 0.01 | |
| 1 year | 0 | 0.01 | |
| 3 years | 0 | 0.28 | |
| 5 years | 0 | 2.15 | |
| 10 years | 0 | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | - | |
Radka Milanova
CTO | Chief Tech/Sci/R&D Officer | 71 | - |
James Smeeding
PRN | Corporate Officer/Principal | - | 2020-05-01 |
| Director | Title | Age | Since |
|---|---|---|---|
James Smeeding
BRD | Director/Board Member | - | 2020-05-01 |
| Director/Board Member | - | - | |
Abdul Nnyenje
BRD | Director/Board Member | - | 2024-10-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-04-24 | Buy | Director | 80,000 | 0.0824% | ||
| 20-09-21 | Other | Chief Executive Officer | 0 | 0% | ||
| 20-09-21 | Buy | Chief Executive Officer | 10,000 | 0.0118% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 117 | ||
| -0.95% | -13.21% | +314.07% | +13.12% | 2.58B | ||
| -4.67% | -18.61% | +156.06% | +135.00% | 1.9B | ||
| -7.27% | -13.61% | -2.20% | +180.18% | 553M | ||
| +5.26% | +13.64% | +25.00% | 0.00% | 51.88M | ||
| Average | -1.53% | -5.94% | +123.23% | +82.07% | 1.02B | |
| Weighted average by Cap. | -2.96% | -15.89% | +217.77% | +76.62% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 0.07 0.06 0.06 0.05 0.1 6.82 0.1 0.68 0.26 3.34 0.27 0.26 11.57 | 0.1 0.08 0.08 0.07 0.13 9.09 0.14 0.9 0.35 4.45 0.36 0.35 15.43 |
| Net income | -10.68M -9.2M -8.47M -7.95M -14.93M -1.01B -15.09M -100M -39M -494M -40.06M -39.21M -1.71B | -3.98M -3.43M -3.16M -2.96M -5.56M -376M -5.62M -37.29M -14.53M -184M -14.92M -14.61M -638M |
| Net Debt | 5.65M 4.87M 4.49M 4.21M 7.91M 534M 7.99M 53M 20.65M 262M 21.21M 20.76M 907M | 6.25M 5.38M 4.96M 4.66M 8.74M 591M 8.83M 58.59M 22.82M 289M 23.45M 22.95M 1B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ALID Stock
Select your edition
All financial news and data tailored to specific country editions
















